Xujuan Hou1, Yujiao Zhang2, Ximin Wang2, Shaohua Zheng2, Yinglong Hou2, Mei Gao2. 1. Department of Cardiology, The Affiliated Hospital of Taishan Medical College Tai'an 271000, Shandong, China ; Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University Jinan 250014, Shandong, China. 2. Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University Jinan 250014, Shandong, China.
Abstract
OBJECTIVE: This study is to investigate the effect of rosuvastatin on atrial nerve sprouting and electrical remodeling after myocardial infarction (MI). METHODS: Rabbit MI model was established by anterior descending branch ligation. These models were divided into the sham (n = 9), MI model (n = 7), and rosuvastatin intervention (n = 8) groups. Immunohistochemistry was used to detect the autonomic atrial nerve distribution. Real-time PCR and Western blot analysis were performed to evaluate the mRNA and protein expression levels, respectively. RESULTS: Our results from immunohistochemistry showed that, compared with the sham group, the densities of tyrosine hydroxylase (TH)- and choline acetyltransferase (CHAT)-positive nerve fibers were significantly elevated in the MI model group. However, TH- and CHAT-positive nerve fibers were significantly decreased by rosuvastatin treatment, suggesting that rosuvastatin could reduce autonomic nerve sprouting in acute MI. Moreover, rosuvastatin decreased the mRNA and protein expression levels of TH in atrial tissues following MI. Compared with the sham group, the mRNA expression level of KCND3 was significantly down-regulated in the MI model group. And, this down-regulation was restored by rosuvastatin treatment. These results suggested that rosuvastatin could inhibit the electrical remodeling in atrium after acute MI. CONCLUSION: Atrial nerve sprouting and electrical remodeling occur following MI, which could be suppressed by rosuvastatin treatment. Our findings provide insights into the understanding of the mechanism through which statins decrease the risk of atrium arrhythmia after MI.
OBJECTIVE: This study is to investigate the effect of rosuvastatin on atrial nerve sprouting and electrical remodeling after myocardial infarction (MI). METHODS:Rabbit MI model was established by anterior descending branch ligation. These models were divided into the sham (n = 9), MI model (n = 7), and rosuvastatin intervention (n = 8) groups. Immunohistochemistry was used to detect the autonomic atrial nerve distribution. Real-time PCR and Western blot analysis were performed to evaluate the mRNA and protein expression levels, respectively. RESULTS: Our results from immunohistochemistry showed that, compared with the sham group, the densities of tyrosine hydroxylase (TH)- and choline acetyltransferase (CHAT)-positive nerve fibers were significantly elevated in the MI model group. However, TH- and CHAT-positive nerve fibers were significantly decreased by rosuvastatin treatment, suggesting that rosuvastatin could reduce autonomic nerve sprouting in acute MI. Moreover, rosuvastatin decreased the mRNA and protein expression levels of TH in atrial tissues following MI. Compared with the sham group, the mRNA expression level of KCND3 was significantly down-regulated in the MI model group. And, this down-regulation was restored by rosuvastatin treatment. These results suggested that rosuvastatin could inhibit the electrical remodeling in atrium after acute MI. CONCLUSION: Atrial nerve sprouting and electrical remodeling occur following MI, which could be suppressed by rosuvastatin treatment. Our findings provide insights into the understanding of the mechanism through which statins decrease the risk of atrium arrhythmia after MI.
Authors: J M Cao; M C Fishbein; J B Han; W W Lai; A C Lai; T J Wu; L Czer; P L Wolf; T A Denton; I P Shintaku; P S Chen; L S Chen Journal: Circulation Date: 2000-04-25 Impact factor: 29.690
Authors: J M Cao; L S Chen; B H KenKnight; T Ohara; M H Lee; J Tsai; W W Lai; H S Karagueuzian; P L Wolf; M C Fishbein; P S Chen Journal: Circ Res Date: 2000-04-14 Impact factor: 17.367
Authors: Moshe Swissa; Shengmei Zhou; Ignacio Gonzalez-Gomez; Che-Ming Chang; Angela C Lai; Adam W Cates; Michael C Fishbein; Hrayr S Karagueuzian; Peng-Sheng Chen; Lan S Chen Journal: J Am Coll Cardiol Date: 2004-03-03 Impact factor: 24.094
Authors: Katarina Andelova; Barbara Szeiffova Bacova; Matus Sykora; Peter Hlivak; Miroslav Barancik; Narcis Tribulova Journal: Int J Mol Sci Date: 2022-01-26 Impact factor: 5.923